Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S52. https://doi.org/10.25251/skin.2.supp.52